Source: Eur Respir J, 56 (5) 2000130; 10.1183/13993003.00130-2020



Rating:

Share or cite this content

Citations should be made in the following way:
John P. Corcoran, Ioannis Psallidas, Stephen Gerry, Francesco Piccolo, Coenraad F. Koegelenberg, Tarek Saba, Cyrus Daneshvar, Ian Fairbairn, Richard Heinink, Alex West, Andrew E. Stanton, Jayne Holme, Jack A. Kastelik, Henry Steer, Nicola J. Downer, Mohammed Haris, Emma H. Baker, Caroline F. Everett, Justin Pepperell, Thomas Bewick, Lonny Yarmus, Fabien Maldonado, Burhan Khan, Alan Hart-Thomas, Georgina Hands, Geoffrey Warwick, Duneesha De Fonseka, Maged Hassan, Mohammed Munavvar, Anur Guhan, Mitra Shahidi, Zara Pogson, Lee Dowson, Natalia D. Popowicz, Judith Saba, Neil R. Ward, Rob J. Hallifax, Melissa Dobson, Rachel Shaw, Emma L. Hedley, Assunta Sabia, Barbara Robinson, Gary S. Collins, Helen E. Davies, Ly-Mee Yu, Robert F. Miller, Nick A. Maskell, Najib M. Rahman. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study. Eur Respir J, 56 (5) 2000130; 10.1183/13993003.00130-2020

Member's Comments

No comment yet.

Related content which might interest you: External assessment and validation of the RAPID score using an international multicentre pleural infection cohort treated with intrapleural fibrinolytics Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes Year: 2021 Risk stratifying pleural infection using RAPID score in an Asian population Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 COVID-19 pneumonia and clinical follow-up: results of a prospective cohort Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study Source: Eur Respir J, 56 (6) 2003498; 10.1183/13993003.03498-2020 Year: 2020 Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study Source: Eur Respir J, 56 (2) 2001104; 10.1183/13993003.01104-2020 Year: 2020 Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study Source: Virtual Congress 2021 – Imaging in COVID-19 Year: 2021 An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study. Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Pleural empyema in hospitalization and mortality risk: application of RAPID score. Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 External validation of the SAPS3-CNIV score to predict hospital mortality following noninvasive ventilation: a retrospective single-centre study Source: ERJ Open Res, 5 (2) 00232-2018; 10.1183/23120541.00232-2018 Year: 2019 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Prospective observational study in patients with obstructive lung disease: NOVELTY design Source: ERJ Open Res, 5 (1) 00036-2018; 10.1183/23120541.00036-2018 Year: 2019 LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study Source: Eur Respir J, 56 (3) 2002113; 10.1183/13993003.02113-2020 Year: 2020 Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020 Year: 2021